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The Nucleosome Remodelling and Deacetylation
complex suppresses transcriptional noise during
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Abstract
Multiprotein chromatin remodelling complexes show remarkable
conservation of function amongst metazoans, even though compo-
nents present in invertebrates are often found as multiple paralo-
gous proteins in vertebrate complexes. In some cases, these
paralogues specify distinct biochemical and/or functional activities
in vertebrate cells. Here, we set out to define the biochemical and
functional diversity encoded by one such group of proteins within
the mammalian Nucleosome Remodelling and Deacetylation
(NuRD) complex: Mta1, Mta2 and Mta3. We find that, in contrast
to what has been described in somatic cells, MTA proteins are not
mutually exclusive within embryonic stem (ES) cell NuRD and,
despite subtle differences in chromatin binding and biochemical
interactions, serve largely redundant functions. ES cells lacking all
three MTA proteins exhibit complete NuRD loss of function and are
viable, allowing us to identify a previously unreported function for
NuRD in reducing transcriptional noise, which is essential for
maintaining a proper differentiation trajectory during early stages
of lineage commitment.
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Introduction
Mammalian cells contain a number of proteins capable of using
ATP hydrolysis to shift nucleosomes relative to the DNA sequence,
thereby facilitating chromatin remodelling. In mammals, these ATP-
dependent chromatin remodelling proteins usually exist within
multiprotein complexes and play essential roles in the control of
gene expression, DNA replication and repair (Hargreaves & Crab-
tree, 2011; Narlikar et al, 2013; Hota & Bruneau, 2016).
Nucleosome Remodelling and Deacetylation (NuRD) is one such
multiprotein complex which is unique in that it contains both chro-
matin remodelling and protein deacetylase activity. NuRD is highly
conserved amongst metazoans and has been shown to play impor-
tant roles in cell fate decisions in a wide array of systems (Denslow
& Wade, 2007; Signolet & Hendrich, 2015). For example, in embry-
onic stem (ES) cells, NuRD controls nucleosome positioning at regu-
latory sequences to finely tune gene expression (Reynolds et al,
2012; Bornelo¨v et al, 2018), and in somatic lineages, NuRD activity
has been shown to prevent inappropriate expression of lineage-
specific genes to ensure fidelity of somatic lineage decisions (Denner
& Rauchman, 2013; Knock et al, 2015; Gomez-Del Arco et al, 2016;
Loughran et al, 2017). It was recently demonstrated that this is
achieved in both ES cells and B-cell progenitors by restricting access
of transcription factors to regulatory sequences (Liang et al, 2017;
Loughran et al, 2017; Bornelo¨v et al, 2018). Additionally,
aberrations in expression levels of NuRD component proteins are
increasingly being linked to cancer progression (Lai & Wade, 2011;
Mohd-Sarip et al, 2017).
Nucleosome Remodelling and Deacetylation is comprised of two
enzymatically and biochemically distinct subcomplexes: a chro-
matin remodelling and a deacetylase subcomplex. The chromatin
remodelling subcomplex contains a nucleosome remodelling
ATPase protein (Chd3/4/5) along with one of the zinc finger
proteins Gatad2a/b and the Doc1/Cdk2ap1 protein, while the
deacetylase subcomplex contains class I histone deacetylase
proteins Hdac1/2, the histone chaperones Rbbp4/7, the Metastasis
Tumour Antigen family of proteins, Mta1, Mta2 and Mta3 and, in
pluripotent cells, the zinc finger proteins Sall1/4 (Lauberth & Rauch-
man, 2006; Allen et al, 2013; Kloet et al, 2015; Bode et al, 2016;
Low et al, 2016; Miller et al, 2016; Spruijt et al, 2016; Zhang et al,
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2016). These two subcomplexes are bridged by Mbd2/3, creating
intact NuRD (Fig 1A). While HDAC and RBBP proteins are also
associated with other chromatin-modifying complexes, the MBD,
GATAD2 and MTA proteins are obligate NuRD components. Func-
tional and genetic data indicate that the CHD4-containing remod-
elling subunit is capable of functioning independently of intact
NuRD (O’Shaughnessy & Hendrich, 2013; O’Shaughnessy-Kirwan
et al, 2015; Ostapcuk et al, 2018). The deacetylase subcomplex has
been shown biochemically to exist outside of intact NuRD, though
whether this subcomplex has any specific function is not clear (Link
et al, 2018; Zhang et al, 2018).
Changes in subunit composition in large multiprotein, chro-
matin-modifying complexes such as PRC1 and BAF have been
shown to correlate with distinct changes in function at sites of
action in a cell-type-specific manner (Ho & Crabtree, 2010; Morey
et al, 2012). The NuRD complex might therefore be expected to
show similar diversity in both composition and function, and in
fact, diversification of NuRD function has been described through
differential incorporation of various isoforms of NuRD component
proteins (Bowen et al, 2004). For example, Mbd2 and Mbd3 are
mutually exclusive within NuRD (Le Guezennec et al, 2006). While
Mbd2 is not required for mammalian development, Mbd3 is essen-
tial at early postimplantation stages in mice (Hendrich et al, 2001).
Mbd2/NuRD is a methyl-CpG binding co-repressor complex which
is dispensable for early development but Mbd3/NuRD, a transcrip-
tional modulator found at sites of active transcription, has been
shown to play important roles in regulation of cell fate decisions in
multiple developmental systems (Feng & Zhang, 2001; Reynolds
et al, 2012, 2013; Gunther et al, 2013; Shimbo et al, 2013; Menafra
et al, 2014). NuRD complexes containing either CHD3, CHD4 or
CHD5 play distinct roles during cortical development (Nitarska
et al, 2016).
Further functional and biochemical diversification occurs
through alternate use of the three MTA proteins within NuRD. MTA
proteins function as a scaffold around which the deacetylase
subcomplex is formed, comprising a 2:2:4 stoichiometry of MTAs:
HDACs:RBBPs (Millard et al, 2013, 2016; Smits et al, 2013; Zhang
et al, 2016). While invertebrates predominantly have a single MTA
protein orthologue, most vertebrates have three. The three mamma-
lian MTA proteins are highly conserved, differing from each other
predominantly at their C-termini (Fig 1A). The MTA1 protein was
originally identified because of its elevated expression in metastatic
cell lines (Toh et al, 1994), and subsequently, all three MTA
proteins have been shown to be upregulated in a range of different
cancer types (Covington & Fuqua, 2014; Sen et al, 2014; Ma et al,
2016). The MTA1 and MTA3 proteins were shown to form distinct
NuRD complexes in breast cancer cells and in B cells and were
recruited by different transcription factors to regulate gene expres-
sion (Mazumdar et al, 2001; Fujita et al, 2003, 2004; Si et al, 2015).
These studies did not detect biochemical interactions between
MTA3 and the other MTA proteins, leading to the conclusion that
MTA proteins are mutually exclusive within NuRD. In contrast,
Mta1 was shown to interact with Mta2 in MEL cells, indicating that
mutual exclusivity may be cell-type-specific (Hong et al, 2005).
While all three Mta genes are expressed in ES cells, detailed
biochemical analysis of interactions of MTA proteins with one
another or with the various NuRD components in ES cells has not
previously been described.
Functional evidence does not support a strict lack of redundancy
amongst MTA proteins during mammalian development. While
zygotic deletion of Chd4 or Mbd3 results in pre- or peri-implantation
developmental failure, respectively (Kaji et al, 2007;
O’Shaughnessy-Kirwan et al, 2015), mice deficient in any one of the
three MTA proteins show minimal phenotypes. Mice lacking either
Mta1 or Mta3 are viable and fertile (Manavathi et al, 2007; Mouse
Genome Informatics), while mice lacking Mta2 show incompletely
penetrant embryonic lethality and immune system defects (Lu et al,
2008). In the current study, we took a systematic approach to
dissecting MTA protein biochemical and functional diversity. We
find that, in contrast to what has been described in somatic cells,
MTA proteins are not mutually exclusive within NuRD in ES cells
and serve largely redundant functions. Furthermore, ES cells lacking
all three MTA proteins are viable and represent a complete NuRD
null, allowing us to identify a previously undetected function for
NuRD in early stages of lineage commitment.
Results
MTA proteins are not mutually exclusive within the NuRD
complex in ES cells
The absence of a detected interaction between the MTA2 and MTA3
proteins in human cells (Fujita et al, 2003; Si et al, 2015), and the
observation that different MTA proteins can show different protein–
protein interactions in B cells (Fujita et al, 2004) have led to the
conclusion that the MTA proteins are mutually exclusive within
NuRD and could hence confer functional diversity to the NuRD
complex (Lai & Wade, 2011). To investigate the biochemical speci-
ficity of the MTA proteins in an unbiased manner, we used gene
targeting of endogenous loci to produce three different mouse ES
cell lines in which an epitope tag was fused to the C-terminus of
each MTA protein (Fig 1A). Although MTA genes show different
expression patterns in preimplantation mouse development, all
three are expressed in peri-implantation and early postimplantation
epiblast, the tissue most similar to the naı¨ve ES cell state (Fig EV1).
We therefore considered ES cells to be a good system in which to
investigate the function of MTA proteins.
Each tagged protein was expressed at levels comparable to those
of wild-type proteins and was found to interact with other NuRD
component proteins by immunoprecipitation (Fig 1B). Each MTA
protein was also able to immunoprecipitate the other MTA proteins
in addition to unmodified forms of itself (Fig 1B). Mta3 was barely
detectable in Mta1-3xFLAG immunoprecipitates by IP-western blot
(though robustly found by mass spectrometry, see below), but Mta1
was robustly detected associating with Mta3-3xFLAG (Fig 1B). This
could indicate that any Mta1-Mta3-containing NuRD complexes
represent a relatively small proportion of nuclear Mta1, but a rela-
tively large proportion of nuclear Mta3. Individual NuRD complexes
contain two MTA proteins (Millard et al, 2013; Smits et al, 2013;
Zhang et al, 2016), so the identification of an interaction between
MTA proteins means that NuRD complexes in ES cells could contain
either homodimers or heterodimers consisting of any combination
of the three MTA proteins.
To investigate the potential biochemical diversification conferred
by different MTA proteins in pluripotent cells, we used our tagged
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cell lines to identify proteins interacting with each of the MTA
proteins by label-free quantitative mass spectrometry. Each protein
robustly co-purified with all known NuRD component proteins,
including each of the MTA proteins, confirming that MTA proteins
are not mutually exclusive within NuRD in ES cells (Fig 1C). In
addition to NuRD components, each of the MTA proteins co-purified
with Wdr5 as well as a number of zinc finger proteins, most of
which had previously been identified as NuRD-interacting proteins
(Bode et al, 2016; Spruijt et al, 2016; Ee et al, 2017; Matsuura et al,
2017).
As NuRD is assembled from a deacetylase subcomplex and a
remodeller subcomplex joined through the Mbd3 protein (Fig 1A),
loss of Mbd3 is expected to result in dissociation of these two
subcomplexes. Endogenous tagging for each MTA protein was
performed in an ES cell line harbouring a floxed Mbd3 allele, and
IP/Mass spectrometry was repeated in ES cells after Mbd3 deletion
in order to enrich for interactions specific for the deacetylase
subcomplex. The majority of interactions with non-NuRD compo-
nents was lost after Mbd3 deletion, indicating that most of these
proteins do not directly associate either with the MTA proteins or
with the deacetylase subcomplex (Fig 1C). Exceptions to this were
Zfp296, which was identified as interacting with all three MTA
proteins in an Mbd3-independent manner, and Pwwp2a, which co-
purified with Mta1 in both wild-type and Mbd3-null cells, consistent
with recent reports (Link et al, 2018; Zhang et al, 2018). Notably,
Zfp219 and Zfp512b both showed Mbd3-independent interactions
specifically with Mta2 (Fig 1C).
By quantitating the abundance of peptides sequenced in each
experiment, we found that the interactomes for both Mta1 and Mta2
showed a depletion of peptides associated with the remodeller
subcomplex (i.e. Chd4, Gatad2a/b and Cdk2ap1) in Mbd3-null cells,
whereas proteins associated with the histone deacetylase subcom-
plex (MTA proteins, Hdac1/2, Sall proteins and Rbbp4/7) remained
present at similar levels (Fig 1D). In contrast, the Mta3 interactome
showed an increased interaction with Mbd2 and no relative loss of
either subcomplex in the absence of Mbd3. Thus, both Mta1 and
Mta2 can form part of a stable histone deacetylase-containing
subcomplex in the absence of intact NuRD, but Mta3 is preferen-
tially found in intact NuRD complexes. All three MTA proteins asso-
ciated with Mbd2 in the absence of Mbd3, indicating that they all
can contribute to Mbd2/NuRD. Together these data show that the
MTA proteins are found exclusively within the NuRD complex in ES
cells.
MTA proteins show subtle differences in genome-wide binding
patterns
To test whether MTA proteins confer differential chromatin binding
to NuRD complexes, we subjected our ES cell lines expressing
epitope-tagged MTA proteins to chromatin immunoprecipitation
followed by high throughput sequencing (ChIP-Seq). The binding
profiles of the three proteins were largely, but not completely over-
lapping (Fig 2A and B). Mta3 binding was almost entirely associated
with Mta1 and/or Mta2 binding, while 31% of Mta1 peaks and 22%
of Mta2 peaks were not associated with any other MTA protein
(Fig 2A and B). The overall efficiency of Mta3-3xFLAG ChIP-seq
was lower than those for Mta1-3xFLAG or Mta2-GFP, possibly due
to the lower levels of Mta3 present in ES cells, although replicates
were highly correlated (Appendix Fig S1). While Mta3-bound sites
can therefore be identified with high confidence, it remains formally
possible that “Mta1-only” or “Mta2-only” sites also contain Mta3,
albeit at levels beneath the detection threshold of our ChIP-seq. The
vast majority of MTA peaks were also bound by Chd4, indicating
that they represent NuRD-bound regions (Figs 2C and D, and EV2A
and B).
Sites found associated with all three MTA proteins were highly
enriched for Chd4 and Mbd3 binding, consistent with these being
core NuRD binding regions (Fig 2D). These sites were also enriched
for marks of active promoters (H3K4Me3, H3K27Ac) and active
enhancers (H3K4Me1, H3K27Ac, P300; Fig 2D and E), both of
which are hallmarks of NuRD-associated regions (Miller et al, 2016;
Bornelo¨v et al, 2018). The same was true for sites bound by any
two of the three MTA proteins (Fig EV2B). The majority of sites
occupied by one MTA protein, but not the other two, were also
occupied by Chd4 but to a lesser extent than is seen at core NuRD
sites (Fig 2D and E). Sites associated with all three MTA proteins,
presumably representing core NuRD-bound sites, were located both
at transcription start sites and at distal locations, while sites bound
by only one MTA protein were predominantly located distal to tran-
scription start sites (Fig EV2C). Whereas Mta2-only and Mta3-only
sites showed some enrichment for both H3K4Me1 and H3K4Me3,
Mta1-only sites showed no enrichment for H3K4Me3 (Fig 2D and
E). In all cases, MTA-only sites lacking Chd4, which could represent
sites of binding by the histone deacetylase subcomplex only,
showed characteristics of inactive enhancers, in that they were
moderately enriched for H3K4Me1 and P300, but not for H3K4Me3,
H3K27Ac or H3K36Me3 (Fig EV2D). None of the MTA-bound
◀ Figure 1. Biochemical characterisation of epitope-tagged MTA proteins.A Schematic of MTA proteins with different protein domains indicated as coloured boxes, and the C-terminal epitope tags indicated. The model below shows the MTA-
and HDAC-containing subunit joined to the CHD4-containing subunit through the MBD protein.
B Tagged MTA proteins in heterozygously targeted cell lines were immunoprecipitated and subsequent western blots probed with antibodies indicated at right. Solid
black triangles indicate the locations of untagged proteins, and open triangles show the position of epitope-tagged proteins in the anti-Mta1, Mta2 or Mta3 panels;
and a grey triangle shows the location of IgG bands in the anti-Mbd3 panel. “Beads” in the Mta2-GFP IP represents a mock immunoprecipitation using beads only,
analogous to the “IgG” controls in the Mta1-3xFLAG and Mta3-3xFLAG IPs. 10% of the input was loaded into “Input” lanes. Molecular weights in kDa are shown at
left. (Full western blot images are available in Mendeley Data.)
C Proteins co-purifying with Mta1, Mta2 or Mta3 in IP-mass spectrometry experiments in wild-type cells (top) or Mbd3-null cells (bottom). Proteins showing significant
enrichment with the bait protein are located outside the dotted lines. For all panels, the protein being immunoprecipitated is indicated in red, the other MTA proteins
in purple, and other NuRD components in blue. Each IP/Mass spec experiment set comprised three independent immunoprecipitations from one nuclear extract
preparation.
D Relative enrichment of indicated proteins in MTA pulldowns from wild-type (WT) or Mbd3-null (Mbd3KO) ES cells, normalised to 2x MTA proteins. NuRD components
comprising the remodelling subunit are labelled in blue, those comprising the deacetylase subunit in red. As MTA proteins are the bait in these experiments, they may
be isolated more efficiently than their interaction partners. Error bars represent standard deviation from three (Mta1 and Mta2) or six (Mta3) replicate pulldowns.
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Figure 2. MTA proteins show similar chromatin binding patterns.
A ChIP-seq peaks identified for Mta1 and Mta2 (left), Mta1 and Mta3 (middle) or Mta2 and Mta3 (right) are plotted by enrichment for each protein. Peaks called for
both proteins are indicated in the overlap.
B Overlap of peaks identified by ChIP-seq for each MTA protein in wild-type ES cells. Total peak numbers are indicated below each protein name. Each ChIP-seq dataset
was made from biological triplicates.
C Comparison of Mta1 and Mta2 peaks with Chd4 peaks, as in Panel (B).
D ChIP-seq enrichment for indicated proteins or histone modifications is plotted across different subsets of Mta-bound sites. Mta1/2/3 refers to peaks identified in all
three ChIP-seq datasets, whereas “Mta1 Only”, “Mta2 Only” or “Mta3 Only” refer to peaks only called for that protein.
E Average enrichment of density plots in (D) is plotted for different subsets of Mta ChIP-seq peaks.
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sequences showed any enrichment for methylated DNA (Fig EV2E).
Genes associated with binding by only one or two MTA proteins,
with or without Chd4, are associated with a similar distribution of
GO terms (Fig EV2F) which is not consistent with the idea that the
MTA proteins are directing NuRD activity to specific gene subsets.
Mta1/Mta2/Mta3 triple knockout is a total NuRD null
To investigate the degree of genetic redundancy amongst the dif-
ferent MTA genes, we obtained gene trap alleles for each gene from
the European Conditional Mouse Mutagenesis Programme (Skarnes
et al, 2011) as ES cell lines (Mta1 and Mta2) or as embryos (Mta3)
(Fig EV3A–C). ES cell lines were used for morula aggregation to
create chimaeric mice which were subsequently outcrossed to estab-
lish a mouse line. Conditional deletion alleles were generated for
each line, which was subsequently bred with females expressing
Sox2-Cre (Hayashi et al, 2002) resulting in deletion of floxed exons
and the absence of any detectable protein production from each
allele (Fig EV3D; see Materials and Methods for details). As has
been reported previously, Mta1/ and Mta3/ mice were viable,
and Mta2/ mice showed incompletely penetrant embryonic lethal-
ity (Manavathi et al, 2007; Lu et al, 2008).
Mta1, Mta2 or Mta3-null ES cell lines derived from mice were
morphologically indistinguishable from wild-type ES cells, as were
ES cell lines deficient for combinations of pairs of MTA genes
(Fig EV3E). While some differences in gene expression could be
identified between single mutants and their respective parent lines
(Fig EV3F and G), these changes were not sufficient to make them
distinct from wild-type ES cells when compared to Mbd3-mutant ES
cells, 3.5 dpc ICM and 4.5 dpc epiblast (Fig EV3H). We therefore
concluded that any gene expression changes identified in single
mutant ES cells were unlikely to be of consequence during early
development, and that MTA proteins show functional redundancy
during early mammalian development.
Mta1/Mta2/Mta3Flox/Flox ES cells (Mta12Δ) were subse-
quently created and expanded in culture. After transfection with a
Cre expression construct to induce deletion of both Mta3 alleles, we
recovered ES cells lacking all three MTA proteins (see Materials and
Methods for details; Fig 3A). These Mta1/Mta2/Mta3/ ES
cells (subsequently referred to as Mta123Δ) appeared morphologi-
cally normal in standard, 2i + LIF culture (Fig 3B), but showed a
considerable degree of spontaneous differentiation in serum/LIF
culture. MTA proteins are therefore dispensable for ES cell viability.
Structurally, MTA proteins bridge an interaction between the
deacetylase subcomplex with Mbd3 and the remodelling subcom-
plex (Fig 1A) so we predicted that loss of all three MTA proteins
would prevent NuRD formation. Consistent with this prediction, we
could detect no interactions between Chd4 and components of the
deacetylase subcomplex (Hdac2, Rbbp4) in Mta123Δ ES cell nuclear
extract by immunoprecipitation of endogenous proteins (Fig 3C).
Surprisingly, despite being transcribed at normal levels, both
Gatad2b and Mbd3 proteins were present at reduced levels in
Mta12Δ cells and barely detectable in Mta123Δ cells (Figs 3C and
EV4A), indicating that the MTAs are important for the stability of
both of these proteins. To investigate this further, we monitored loss
of protein stability in Mta1/Mta2/Mta3Flox/Flox ES cells after
deletion using a tamoxifen-inducible Cre (Fig 3D). Loss of Mbd2,
Mbd3, Gatad2a and Gatad2b protein stability was all coincident with
loss of Mta3 protein, although Mbd3 and Gatad2b were already at
reduced levels in the starting cell line (Mta12ΔMta3Flox/Flox)
(Fig 3D). Gatad2b and Mta3 also show reduced protein stability in
Mbd3Δ ES cells, indicating that a particular inter-dependency exists
between these three proteins for stability (Fig EV4B). Furthermore,
introduction of either Mta1, Mta2 or Mta3 into Mta123Δ ES cells at
levels comparable to wild-type expression resulted in restoration of
Mbd3 protein levels, demonstrating that contact with at least one of
the MTA proteins is sufficient for Mbd3 protein stability (Fig 3E). In
contrast to Mbd3-null ES cells which display a significant depletion,
but not a complete loss of NuRD due to partial compensation by
Mbd2 (Kaji et al, 2006), Mta123Δ ES cells were completely devoid
of any detectable intact NuRD (Fig 3C and F). The Mta123Δ ES cells
are thus a total NuRD-null ES cell line, which allowed us to exam-
ine, for the first time, the consequences of a complete loss of the
NuRD complex in a viable mammalian cell system.
NuRD suppresses transcriptional noise
Twice as many genes showed an increase rather than a decrease in
expression levels in Mta123Δ ES cells compared to control ES cells
by RNA-seq (Fig 4A). The ratio of increased to decreased gene
expression in Mta123Δ cells was very similar for genes bound by all
three MTA proteins, Mta1+2, Mta1 only or Mta2 only (Fig 4B).
NuRD’s global impact on transcription is therefore not grossly
altered by the inclusion or absence of individual MTA subunits.
Comparing global gene expression profiles using principal
component analysis (PCA) showed that Mta123Δ and Mbd3Δ ES
▸Figure 3. Mta1/Mta2/Mta3 triple-null ES cells represent a complete NuRD KO.A Western blots of wild-type (Control), double or triple-null ES cell nuclear extract were probed with antibodies indicated at right. LaminB1 acts as a loading control.
Approximate sizes are indicated in kDa.
B Phase-contrast images of wild-type or Mta123Δ ES cells in 2i+LIF conditions. Scale bars represent 100 lm.
C Western blots of anti-Chd4 immunoprecipitation of nuclear extract from indicated cell lines (top) probed with antibodies indicated at right. For the Gatad2b and
Mbd3 blots, arrowheads indicate target proteins, while an asterisk marks a non-specific IgG bands. 10% of the input was loaded into “Input” lanes. Approximate sizes
are indicated in kDa.
D Western blot of a time course of Mta3 deletion in Mta1ΔMta2ΔMta3Flox/Flox: Cre-ER (Mta12Δ3F/F) or Control (Mta12Δ3F/F without Cre-ER) ES cells probed for indicated
NuRD component proteins or RNA polymerase II as a loading control (aRNAPII). The time course is indicated at the top as Days + tamoxifen.
E Western blot showing rescue of Mta123Δ ES cells by ectopic expression of Mta1, Mta2 or Mta3 from a transgene (TG). Total RNA polymerase II acts as a loading
control (aRNAPII). For all western blots, molecular weight is indicated at left in kDa.
F Model of NuRD complex structure. Upon loss of Mbd3, most of the NuRD complex falls apart into the Chd4-containing remodeller subcomplex and the MTA-
containing deacetylase subcomplex, but some intact Mbd2-NuRD still remains. Upon loss of all three MTA proteins, no intact NuRD remains, both Mbd3 and
Gatad2a/b become unstable and neither of the intact subcomplexes remain.
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cells in self-renewal conditions were more similar to each other than
either was to wild-type cells (Fig 4C). Mta123Δ ES cells were most
distinct from wild-type cells, consistent with them representing a
more complete NuRD knockout (Fig 4C). Consistent with this, genes
driving the NuRD-specific separation (Principal Component 2; PC2)
were generally misexpressed to a greater degree in Mta123Δ ES cells
than in Mbd3Δ ES cells (Fig EV4C). Genes misexpressed in either
Mbd3Δ or Mta123Δ ES cells were most significantly associated with
the same top three GO terms, but the significance was greater in
Mta123Δ ES cells as these cells misexpressed more genes in each
category and generally to a greater extent than did the Mbd3Δ cells
(Figs 4D and E, and EV4C).
Genes misexpressed in Mta123Δ ES cells were predominantly
those normally expressed at lower levels (Fig EV4D). A very similar
pattern was seen if we considered genes misexpressed in Mbd3Δ ES
cells, with the major difference being that more genes were misex-
pressed in the Mta123Δ cells. The predominant biochemical dif-
ference between the Mbd3Δ cells and Mta123Δ cells was the lack of
Mbd2/NuRD and of the MTA/HDAC subcomplex in the triple
mutants, so we next asked whether we could detect evidence for
specific functions for either of these complexes in ES cells. We iden-
tified genes near core NuRD peaks (N = 15,210), near Mta-only
peaks (regardless of the presence of a NuRD peak; N = 10,280),
genes associated with NuRD components Chd4 and MTAs, but not
Mbd3 (presumptive Mbd2/NuRD-only genes; N = 349), and genes
containing MTA-only peaks, but no Chd4 peak (MTA-only genes;
N = 151) (Fig 4F) and divided them into expression quartiles. While
there are very few genes not associated with a NuRD peak, those
few presumptive Mbd2/NuRD-only genes or MTA-only genes
showed a similar misexpression pattern to those seen for core NuRD
genes, in that the majority of misexpressed genes was in the second
lowest expression quartile (Fig 4F). We therefore find no evidence
for a specific gene regulatory function associated with an MTA/
HDAC subcomplex. This is consistent with a recent report in which
loss of Pwwp2a/b resulted in only very slight alterations in nascent
RNA production amongst a small subset of genes (Zhang et al,
2018). Nevertheless, this analysis further highlights the importance
for NuRD in suppressing expression of lowly expressed genes. We
therefore conclude that, in addition to fine-tuning gene expression
as part of the Mbd3/NuRD complex, MTA proteins are also impor-
tant for preventing inappropriate activation of a variety of different
genes, or in preventing transcriptional noise in ES cells.
The NuRD complex safeguards cellular identity
during differentiation
We next asked what impact complete loss NuRD activity had upon
the differentiation capacity of Mta123Δ ES cells. Upon removal of
the two inhibitors and LIF from the culture media, wild-type cells
began to adopt the flatter morphology of neuroectoderm (Fig 5A;
Ying et al, 2003). This was accompanied by downregulation of
pluripotency-associated genes and the activation of a neural gene
expression programme (Fig 5B). Mbd3Δ ES cells are able to respond
to the absence of self-renewal factors but have a very low probabil-
ity of adopting a differentiated fate when induced to differentiate in
N2B27 conditions (Kaji et al, 2006; Reynolds et al, 2012). Consistent
with these findings, after 5 days in differentiation conditions Mbd3Δ
ES cells showed some signs of having responded to differentiation
conditions, but still retained pockets of morphologically undifferen-
tiated cells (Fig 5A, Middle). In contrast, the completely NuRD-null
Mta123Δ ES cells appeared to have all exited the self-renewal
programme and adopted a flat, monolayer morphology (Fig 5A,
Bottom). The ability of Mta123Δ ES cells to undergo morphologi-
cally normal neuroectodermal differentiation was rescued upon re-
expression of either Mta1, Mta2 or Mta3 (Fig EV5A).
Since the differentiation process may be considered as a combi-
nation of exit from self-renewal (downregulation of pluripotency-
associated genes) and acquisition of lineage-specific gene expression
programmes, we focussed on changes to these two classes of genes
by RT–qPCR over a differentiation time course. Pluripotency-asso-
ciated genes such as Esrrb, Nanog and Pou5f1 were downregulated
during differentiation of wild-type, Mbd3Δ and Mta123Δ ES cells
(Fig 5B). While this downregulation was not absolutely dependent
on the presence of functional NuRD, the magnitude and kinetics of
the response varied in a gene-dependent manner. Genes associated
with acquisition of neural fate such as Nestin, Pax6, Ascl1 and Cdh2
◀ Figure 4. MTA proteins act redundantly to control gene expression.A Comparison of gene expression in Mta123Δ ES cells and wild-type (WT) ES cells. Red circles indicate spike-in controls, blue circles indicate genes that are not
differentially expressed to a significant degree, and green circles indicate differentially expressed genes (2,404 increased, 1,293 decreased) defined with an adjusted P-
value < 0.05 and a log2 fold-change > 1. N = 3 for each genotype.
B Fold-change in gene expression is plotted for different subsets of genes. All genes are plotted in black, while subsets of genes located nearest to ChIP-seq peaks for
the indicated proteins +Chd4 and which show significant changes in expression compared to wild-type cells are plotted in dashed coloured lines as indicated. The
number of genes in each of the Mta categories are as follows: all genes (32,271), all differentially expressed (n = 3,701), Mta1 + 2 + 3 (n = 1,738), Mta1 + 2
(n = 1,460), Mta1 (n = 1,020) and Mta2 (n = 924).
C Principal component analysis of RNA-seq data from ES cell lines of indicated genotypes in either self-renewing conditions (2iL) or after 48 h in the absence of two
inhibitors and LIF (48 h N2B27). Each point represents a biological replicate.
D GO term enrichment for genes differentially expressed in Mta123Δ ES cells (left) or Mbd3Δ ES cells (right) compared to wild-type cells in 2iL conditions. For each
comparison, the top five most significant gene ontology terms are plotted by log10 of the Benjamini-adjusted p-value. The significant GO terms and P-values were
calculated using David v.6.8 (da Huang et al, 2009a).
E Genes associated with indicated GO terms plotted by fold-change in expression in Mta123Δ ES cells (x-axis) or Mbd3Δ ES cells (y-axis). Genes are coloured if they are
differentially expressed (log2 fold-change > 1 and adjusted P-value < 0.05) in either comparison as indicated. The dotted lines show the fold-change cut-off of 2. GO
terms were identified using David v.6.8 using a Benjamini score with a cut-off of 0.05.
F Genes associated with core NuRD peaks, with an MTA-only peak, with a Chd4 peak and an MTA-peak but not an Mbd3 peak (Chd4 + Mta-Mbd3 genes), or with an
MTA-peak but not a Chd4 peak (MTA-only genes) were divided into quartiles based upon expression levels in wild-type cells. Change in gene expression is plotted on
the x-axis and calculated significance of the expression change on the y-axis. Those genes significantly misexpressed (|log2FC| > 1; P ≤ 0.05) are indicated in red, and
genes showing no significant change are plotted in black. The percentage of genes within each quartile which is significantly misexpressed is indicated at the top of
each plot.
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were activated in the presence of wild-type NuRD, but this response
was reduced or absent in the NuRD mutant lines (Fig 5B). In
contrast, Mta123Δ ES cells aberrantly expressed markers of inappro-
priate lineages, such as Elf5 and Gata3 (trophectoderm—but not
Cdx2 or Eomes), Ebf4, Nobox and Hcn4 (genes associated more
generally with later stages of differentiation or transmembrane
transport). Misexpression of these genes was also seen in Mbd3Δ
cells, although not always to the same extent. Exogenous expression
of either Mta1, Mta2 or Mta3 was able to rescue the ability of
Mta123Δ ES cells to activate neural gene expression to different
extents during differentiation (Fig EV5B), consistent with their abil-
ity to rescue morphological phenotypes.
The morphology of Mta123Δ cells induced to differentiate
towards neuroectoderm was quite different from that of Mbd3Δ cells
(Fig 5A), but there was no large-scale difference in gene categories
changing between the two mutant lines after 48 h in differentiation
conditions (Fig EV5C). In general, Mta123Δ cells misexpressed more
genes from each category and to a greater extent than did Mbd3Δ
cells (Fig EV5D), indicating that their abnormal morphology in dif-
ferentiation conditions is most likely due to widespread gene misex-
pression generally, rather than activation of a specific differentiation
pathway. Mta123Δ ES cells induced to differentiate towards a meso-
derm fate similarly failed to appropriately activate differentiation
markers, and exogenous expression of individual MTA proteins was
again able to rescue the defect to varying degrees (Fig EV5E).
To assess the differentiation potential of Mta123Δ ES cells in an
unbiased manner, we allowed control, Mbd3Δ and Mta123Δ ES cells
to differentiate in embryoid bodies in basal media supplemented
with serum (Doetschman et al, 1985). After 12 days, control cells
had formed colonies containing numerous morphologically distin-
guishable cell types, silenced pluripotency-associated gene expres-
sion and activated expression of genes associated with all three
germ layers (Fig 5C and D). In contrast, both Mbd3Δ and Mta123Δ
cells showed less vigorous outgrowths consisting predominantly of
a monolayer of flat cells (Fig 5C). While both mutant lines were
able to silence expression of pluripotency-associated genes, both
showed reduced activation of differentiation-associated genes, with
Mta123Δ cells generally showing more profound expression defects
than Mbd3Δ cells (Fig 5D). Together these data show that while
NuRD is not strictly required for silencing of pluripotency genes, its
activity is required for proper activation of lineage-appropriate
genes and repression of lineage-inappropriate genes during differen-
tiation.
To better understand how NuRD-null cells respond when
induced to differentiate, we compared their gene expression profiles
to a transcription landscape made from single cells taken from early
mouse embryos (Figs 5E and EV5F and G) (Mohammed et al,
2017). In the self-renewing state, Mbd3D and Mta123D cells clus-
tered near control (parental) lines near embryonic day 3.5 (E3.5)
and E4.5 inner cell mass cells, as is expected for naı¨ve mouse ES
cells (Boroviak et al, 2014). After 48 hours of differentiation, control
ES lines clustered with E5.5 epiblast cells, indicating that the ES cell
differentiation process occurred analogously to development in vivo.
While Mbd3D ES cells appear to have exited the self-renewing state
and to have taken the same differentiation trajectory as wild-type
cells (i.e. leftwards along PC1; Figs 5E and EV5G), they did not
travel as far along this trajectory as wild-type cells, instead occupy-
ing a space between the E4.5 and E5.5 epiblast states. Mta123D cells
travelled even less far along PC1 than Mbd3Δ ES cells, and rather
than maintain the appropriate differentiation trajectory they also
travelled along PC2, occupying a space between E4.5 epiblast and
E4.5 primitive endoderm. This further demonstrates that not only is
NuRD important for cells to be able to adopt the appropriate gene
expression programme for a given differentiation event, but it is also
important for cells to maintain an appropriate differentiation
trajectory.
If Mta123Δ ES cells were undergoing a specific trans-differentia-
tion event towards trophectoderm during ES cell differentiation,
then this could become more pronounced if exposed to normal dif-
ferentiation conditions in a chimaeric embryo. If, in contrast, they
are simply unable to differentiate properly, they would not be
expected to contribute to early embryos. To distinguish between
these possibilities, we assessed the ability of Mta123Δ ES cells to
differentiate in chimaeric embryos. Equal numbers of control or
Mta123Δ ES cells expressing a fluorescent marker were aggregated
with wild-type morulae and allowed to develop for 48 hours.
While wild-type cells contributed to the ICM of host embryos with
100% efficiency, Mta123Δ ES cells showed significantly reduced
contribution and increased levels of apoptosis (Figs 6A and B, and
EV5H). Those Mta123Δ cells that did survive in blastocysts were
predominantly, but not always found in the inner cell mass. These
cells expressed Sox2 but not Cdx2, indicating that they had not
undergone inappropriate differentiation towards a trophectoderm
fate (Fig 6A and B). Nevertheless, no Mta123Δ cells could be
found in E5.5 dpc embryos, indicating that they were unable to
adapt to developmental cues and form epiblast. This is most
consistent with Mta123Δ cells being unable to enter a normal dif-
ferentiation path in an ICM environment. The ability to contribute
to the ICMs of chimaeric embryos was rescued by constitutive
expression of Mta2 in Mta123Δ cells (Fig 6B). We therefore
propose that NuRD not only functions to establish the correct
lineage identity of cells during the differentiation process, but also
◀ Figure 5. NuRD activity maintains an appropriate ES cell differentiation trajectory.A Phase-contrast pictures of ES cells of indicated genotypes after 5 days in neuroectoderm differentiation conditions (N2B27). White arrowheads in the Mbd3Δ panel
indicate pockets of ES-like cells. Scale bars represent 100 lm.
B Expression of indicated genes in the neuroectoderm differentiation time course was measured by RT–qPCR in Control (green) Mta123Δ (magenta) or Mbd3Δ (blue) ES
cells. N ≥ 3 biological replicates, error bars indicate SEM.
C Phase-contrast images of embryoid body outgrowths of indicated genotypes after 12 days in differentiation conditions (N2B27 + 10% serum). Scale bars represent
100 lm.
D Expression of indicated genes in embryoid body cultures over time was measured by RT–qPCR as in Panel (B).
E Comparison of expression data for wild-type, Mbd3Δ or Mta123Δ ES cells in self-renewing (2iL) conditions or after 48 hours in differentiation conditions (48 h N2B27)
with mouse embryonic single cell RNA-seq data from Mohammed et al (2017). Larger shading encloses biological replicates, and smaller circles represent individual
cells. PC4 vs PC1 is plotted in Fig EV5F and a loading plot in EV5G.
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Figure 6. NuRD-null ES cells cannot contribute to normal embryonic development.
A Composite images of representative chimaeric embryos made with control (Mta1Flox/Mta2+/+Mta3Flox/Flox) or Mta123Δ ES cells. ES-derived cells express the Kusabira
Orange fluorescent marker. Sox2 indicates epiblast cells and Cdx2 is expressed in trophectoderm cells. Arrows indicate examples of K-Orange expressing cells in the
mutant embryos. Scale bars = 20 lm.
B (Top) Number of K-Orange expressing cells observed in chimaeric embryos obtained using control ES cells, Mta123Δ ES cells or Mta123Δ ES cells in which Mta2 was
reintroduced on a constitutively expressed transgene (Mta123Δ + Mta2TG). P-values calculated using a two-tailed t-test. (Middle) Mean number of K-Orange cells per
embryo separated by Sox2 expression. P-values calculated using a two-tailed t-test. (Bottom) Number of K-Orange and Caspase-3-positive cells per embryo. P-values
calculated using a one-tailed t-test: *P < 0.05, ****P < 0.0001, “ns” = not significant.
C Model of NuRD function during differentiation of pluripotent cells. NuRD facilitates lineage commitment of ES cells after exit from pluripotency (red arrows), allowing
cells to form differentiated cell types (Top). In the absence of Mbd3, residual NuRD activity ensures cells retain the appropriate differentiation trajectory, but the cells
are unable to reach a differentiated cell fate (dotted red arrows; Middle). In the absence of all three MTA proteins, there is no residual NuRD activity and ES cells are
unable to either achieve appropriate lineage commitment, or to maintain the proper differentiation trajectory (dotted arrows, Bottom).
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prevents inappropriate gene expression to maintain an appropriate
differentiation trajectory (Fig 6C).
Discussion
Here, we provide a biochemical and genetic dissection of the core
NuRD component MTA proteins in mouse ES cells. In contrast to
what has been found in somatic cell types, MTA proteins are not
mutually exclusive in ES cell NuRD complexes and all combina-
tions of MTA homo- and heterodimers can exist within NuRD.
Different MTA proteins exhibit subtle differences in chromatin
localisation or biochemical interaction partners, but we find no
evidence for protein-specific functions in self-renewing or differen-
tiating mouse ES cells. ES cells completely devoid of MTA
proteins are complete NuRD nulls and are viable but show inap-
propriate expression of differentiation-associated genes, are unable
to maintain an appropriate differentiation trajectory and do not
contribute to embryogenesis in chimaeric embryos.
Protein subunit diversity is often found in chromatin remodelling
complexes which specifies functional diversity (Hargreaves & Crab-
tree, 2011; Morey et al, 2012; Hota & Bruneau, 2016). This is also
the case for the NuRD complex, where alternate usage of Mbd2/3,
Chd3/4/5 and Mta1/2/3 has been found to result in alternate func-
tions for NuRD complexes (Feng & Zhang, 2001; Fujita et al, 2003;
Nitarska et al, 2016). Yet the findings by us and others (Manavathi
et al, 2007 and Mouse Genome Informatics) that Mta1 and Mta3-
null mice are viable and fertile, and that we detect no major dif-
ferences in the abilities of different MTA proteins to rescue the
Mta123Δ ES cell phenotypes indicate that MTA proteins exhibit
considerable functional redundancy during development. The MTA
protein family expanded from a single copy to three orthologues
near the base of the vertebrate clade. Triplication of this protein
family may have allowed early vertebrates to diversify NuRD func-
tion in specific somatic tissues, conferring a selective advantage.
Our finding that MTA proteins are functionally redundant in early
embryonic development indicates that the ancestral, essential func-
tion of the MTA proteins in early development has been retained by
all three mammalian orthologues.
Different MTA proteins are capable of interacting with each
other in ES cells, so how the mutual exclusivity reported in other
cell types might be achieved is not clear. One possibility is that the
variable inclusion in NuRD of zinc finger proteins, such as the Sall
proteins in ES cells, could influence the MTA makeup of NuRD
complexes. This class of variable NuRD interactors, which include
Sall1/2/3/4, Zfp423 (Ebfaz), Zfpm1/2 (Fog1/2) and Bcl11b, interact
with RBBP and/or MTA proteins via a short N-terminal motif (Hong
et al, 2005; Lauberth & Rauchman, 2006; Lejon et al, 2011). Of this
class of proteins, Sall1 and Sall4 are the most highly expressed in
ES cells, and Sall4 can associate with all three MTA proteins
(Fig 1C; Miller et al, 2016). In contrast, the Zfpm1 (Fog1) protein
was shown to preferentially associate with Mta1 and Mta2, but not
Mta3, in a somatic cell line (Hong et al, 2005). Hence, it is possible
that different proteins using this N-terminal motif to interact with
NuRD in different cell types could act to skew the proportion of dif-
ferent MTA proteins included in the NuRD complex.
This genetic dissection has revealed that NuRD component
proteins display a large degree of inter-dependence for protein
stability, as has been reported for other multiprotein complexes
(Roumeliotis et al, 2017). Mta1 and Mta2 both contain two
distinct RBBP interaction domains, while Mta3 lacks the C-term-
inal most RBBP interaction domain (Millard et al, 2016). The
Mta1 and Mta2 proteins show minimal loss of stability in the
absence of Mbd3, but Mta3 requires an interaction with Mbd3 to
be completely stable (Fig EV4B; Bornelo¨v et al, 2018). It is possi-
ble that the additional interaction with an Rbbp protein confers
stability to Mta1 and Mta2 in the absence of Mbd3. This would
be consistent with our interpretation that Mta3 preferentially
exists within an intact NuRD complex (Figs 1 and 2). Rbbp4/7
confers histone H3 binding to the NuRD complex, so Mta3-
containing NuRD may bind chromatin less tightly than Mta1-
and/or Mta2-containing NuRD.
We have used pluripotent cells lacking Mbd3 extensively to
show that NuRD plays important roles in control of gene expres-
sion during early stages of exit from pluripotency in vivo and in
culture (Kaji et al, 2006, 2007; Latos et al, 2012; Reynolds et al,
2012). Mbd3-null ES cells contain Mbd2/NuRD and thus repre-
sent a NuRD hypomorph, rather than a NuRD-null. ES cells lack-
ing all three MTA proteins show no detectable NuRD formation
(Fig 3), and therefore, we believe, represent a true NuRD null.
Mta123Δ ES cells are similar to Mbd3Δ ES cells in that both
misexpress a range of genes in 2iL conditions and both fail to
properly differentiate. Yet the Mta123Δ ES cells misexpress more
genes and generally to a greater extent than do Mbd3Δ cells in
both self-renewing and differentiation conditions, and they show
more pronounced differentiation defects. We propose that this
phenotype is a direct consequence of NuRD’s function in
suppressing transcriptional noise during cell fate decisions.
Moderate amounts of noise in the Mbd3Δ state allow cells to
maintain a differentiation trajectory, but interfere with their abil-
ity to achieve the appropriate differentiation state (Fig 6C). In the
higher levels of noise, characteristic of a complete absence of
NuRD cells are unable to appropriately follow differentiation cues
and maintain a coherent differentiation trajectory (Fig 6C). We
therefore propose that NuRD encodes a highly conserved, redun-
dant function to prevent transcriptional noise, as well as a
further, Mbd3-dependent function to fine tune transcriptional
outputs during differentiation.
Materials and Methods
Mouse embryonic stem cells
Mouse embryonic stem (ES) cells were grown on gelatin-
coated plates in 2i/LIF conditions as described (Ying et al,
2008). All lines were routinely PCR genotyped and tested for
mycoplasma. All ES cell lines used in this study are listed in
Table EV1.
The following “Knockout First” alleles were obtained from
EUCOMM as heterozygous ES cell lines (Illustrated in Fig EV1A and
B):
Mta1tm1a(EUCOMM)Wtsi: https://www.mousephenotype.org/data/al
leles/MGI:2150037/tm1a(EUCOMM)Wtsi
Mta2tm1a(EUCOMM)Wtsi: https://www.mousephenotype.org/data/al
leles/MGI:1346340/tm1a(EUCOMM)Wtsi
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Embryonic stem cells were used to derive mouse lines by blasto-
cyst injection using standard methods. ES cell derivation was
performed by isolating ICMs and outgrowing in 2i/LIF media as
described (Nichols et al, 2009).
The epitope-tagged ES cell lines Mta1-Avi-3×FLAG and Mta2-GFP
were generated by traditional gene targeting, while the Mta3-Avi-
3×FLAG line was generated using a CRISPR/Cas9 genome editing
approach. Mta3 contains three alternate stop codons in exons 14, 16
and 17, with exon 15 accessed by alternate usage of a splice donor
site in exon 14. Visual inspection of our RNA-seq data on a genome
browser showed very little transcription beyond exon 14 in ES cells,
indicating that the short isoform was predominant (Appendix Fig
S2). We therefore targeted the stop codon present in exon 14 and
simultaneously destroyed the alternate splice donor site using a
synonymous mutation (GAA TGT to GAA TGC) to prevent splicing
around our inserted construct in the targeted allele. The following
sequences were targeted by guide RNAs in this experiment: 50-G
GCAAGGAGCGGAACGCGGA-30 and 50-GGATGGCAAGGAGCGGAA
CG-30. All MTA epitope-tagged lines were made in an Mbd3Flox/
background (Kaji et al, 2006).
Mta123Δ ES cells were made by targeting Mta2 in Mta1Δ/Δ
Mta3Flox/Flox ES cells. Guide RNAs targeting exons 2 and 18 of Mta2
were transfected along with a targeting construct designed to replace
exons 2–18 with a puromycin expression cassette. The resulting ES
cell lines had replaced exon 2–18 with the selection cassette on one
allele and had a deletion of the same exons on the other allele. The
following sequences were targeted by guide RNAs: exon 2 (50-TA
GACGTAATCTGTAGGAGG-30 and 50-AAATAGACGTAATCTGTAG
G-30) and exon 18 (50-AAATGCGCCGAGCGGCCCGA-30 and 50-TCAC
CTGGAAATGCGCCGAG-30).
Embryonic stem cells were induced to differentiate towards a
neuroectoderm fate by removal of two inhibitors and LIF and
culturing in N2B27 media as described (Ying et al, 2008).
Mesendoderm differentiation was performed as follows: ES cells
were plated at 104 cells/cm2 in N2B27 on fibronectin-treated 6-
well plates and cultured for 48 h. Medium was then replaced with
10 ng/ml activin A and 3 lM CHIR99021 in N2B27 and cultured
further. Embryoid bodies were allowed to form by allowing
~500 cells to aggregate in hanging drops of N2B27 media supple-
mented with 10% foetal calf serum. After 3 days, embryoid
bodies were allowed to attach and outgrow on gelatin-coated
plates in N2B27 + serum. Experiments were carried out in
quadruplicate.
Mice
All animal experiments were approved by the Animal Welfare and
Ethical Review Body of the University of Cambridge and carried out
under appropriate UK Home Office licences. The Mta3 “Knockout
First” allele was obtained from EUCOMM as a heterozygous mouse
line (Illustrated in Fig EV1C):
Mta3tm3a(KOMP)Wtsi: (https://www.mousephenotype.org/data/allele
s/MGI:2151172/tm3a%2528KOMP%2529Wtsi?).
Heterozygous knockout first mouse lines were crossed to a
Flp-deleter strain kindly provided by Andrew Smith (University of
Edinburgh; Wallace et al, 2007) to generate conditional alleles. Mice
harbouring conditional alleles were crossed to a Sox2-Cre transgenic
line (Hayashi et al, 2002) to create null alleles. Mouse lines created
in this study are listed in Table EV1.
Chimaeric embryos were made by morula aggregation with 8–10
ES cells per embryo as described (Hogan et al, 1994) and cultured
for 24–48 h prior to fixation and immunostaining. ES cells used
stably expressed a PiggyBac Kusabira Orange transgene.
Nuclear extracts and immunoprecipitation
For extraction of nuclear proteins, ES cells were lysed in ice cold
Buffer A (10 mM HEPES, pH7.9, 1.5 mM MgCl2, 10 mM KCl and
0.5 mM DTT) supplemented with protease inhibitors and containing
0.6% NP-40. Nuclear pellets were washed further with Buffer A to
reduce cytoplasmic protein contamination before extraction by
vigorous shaking at 4°C for 1 hour in ice cold Buffer C (10 mM
HEPES, pH7.9, 12.5% glycerol, 0.75 mM MgCl2, 10 mM KCl,
0.5 mM DTT) with protease inhibitors followed by centrifugation to
remove insoluble fraction.
For immunoprecipitation of FLAG-tagged proteins, anti-FLAG
antibody was incubated with Protein G Sepharose beads (Sigma) for
1 h at room temperature. Nuclear extract (200 lg) was diluted in IP
Buffer (50 mM Tris–Hcl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1%
Triton X-100, 0.1% SDS, 0.1% DOC) in the presence of protease
inhibitors and benzonase and incubated with antibody-bead conju-
gates at 4°C overnight. Beads were washed three times in ice cold IP
Buffer and a further two times in IP Buffer containing 300 mM
NaCl.
Chd4 immunoprecipitations were carried out at 4°C overnight
using antibody to endogenous Chd4 with Protein G sepharose in
50 mM Tris–Hcl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-
100, 10% glycerol and washed as for the FLAG IPs before SDS–PAGE.
For immunoprecipitation of GFP-tagged proteins, Chromotek
GFP-Trap agarose beads were used. Nuclear extract (200 lg) was
incubated with 25 ll GFP-Trap beads in GFP IP buffer (10 mM Tris,
pH 7.5, 150 mM NaCl, 0.5 mM EDTA) with Benzonase and protease
inhibitors for 1 h at 4°C. Beads were washed five times in IP buffer
prior to western blotting.
IPs were carried out in bulk and loaded on multiple SDS gels for
western blot analysis with various antibodies. Antibodies are listed
in Table EV2.
Label-free pulldowns and label-free quantitation (LFQ) LC-MS/MS
analysis
Label-free GFP pulldowns were performed in triplicate as previously
described (Kloet et al, 2018). 2 mg of nuclear extract was incubated
with 7.5 ll GFP-Trap beads (Chromotek) or 15 ll FLAG-sepharose
beads (Sigma) and 50 lg/ml ethidium bromide in Buffer C
(300 mM NaCl, 20 mM HEPES/KOH, pH 7.9, 20% v/v glycerol,
2 mM MgCl2, 0.2 mM EDTA) with 0.1% NP-40, protease inhibitors
and 0.5 mM DTT in a total volume of 400 ll. After incubation, 6
washes were performed: 2 with Buffer C and 0.5% NP-40, 2 with
PBS and 0.5% NP-40, and 2 with PBS. Affinity purified proteins
were subject to on-bead trypsin digestion as previously described
(Smits et al, 2013). In short, beads were resuspended in 50 ll
elution buffer (2 M urea, 50 mM Tris, pH 7.5, 10 mM DTT) and
incubated for 20 min in a thermoshaker at room temperature. After
addition of 50 mM iodoacetamide (IAA), beads were incubated for
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10 min in a thermoshaker at room temperature in the dark. Proteins
were then on-bead digested into tryptic peptides by addition of
0.25 lg trypsin (Promega) and subsequent incubation for 2 h in a
thermoshaker at room temperature. The supernatant was trans-
ferred to new tubes and further digested overnight at room temper-
ature with an additional 0.1 lg of trypsin. Tryptic peptides were
acidified and desalted using StageTips (Smits et al, 2013) prior to
mass spectrometry analyses.
Chromatin immunoprecipitation (ChIP), sequencing and analysis
Chromatin immunoprecipitations were carried out as previously
outlined (Reynolds et al, 2012). For sequencing of ChIP DNA,
samples from six (Mta1-FLAG and Mta2-GFP) and four (Mta3-
FLAG) individual ChIP experiments were used. Antibodies used are
listed in Table EV2. ChIP-seq libraries were prepared using the
NEXTflex Rapid DNA-seq kit (Illumina) and sequenced at the CRUK
Cambridge Institute Genomics Core facility (Cambridge, UK) on the
Illumina platform. Low-quality reads and adaptor sequences were
removed by Trim Galore! (version: 0.4.1, https://github.com/Fe
lixKrueger/TrimGalore). The trimmed ChIP-seq reads were aligned
to the mouse reference genome (GRCm38/mm10) using bowtie (ver-
sion: 0.12.8; options: -m 1 -v 1; Langmead, 2010). This was followed
by peak calling using macs2 callpeaks against the corresponding
inputs using default parameters and a Q-value of <0.05. The
R/Bioconductor Diffbind package was used to compare each combi-
nation of bound MTA proteins against all others using cut-off values
of RPKM > 1.5, logFC > 1 and FDR < 0.05. The peaks were
processed and visualised by deepTools computeMatrix and
plotHeatmap (Ramirez et al, 2014). Venn diagrams were plotted
using the R/Bioconductor ChIPseeker package.
DNA Methylation data were obtained from Shirane et al (2016),
low-quality reads and adaptor sequences were removed by Trim
Galore! (version: 0.4.1), and reads were aligned to the mouse reference
genome (GRCm38/mm10) using Bismark (version: 0.20.0; Krueger &
Andrews, 2011). Alignments were de-duplicated and further processed
using Methpipe. Only CpGs with a coverage of at least 3 reads were
considered. CpG methylation levels were visualised by deepTools
using a sliding window of 250 bp to give a smoothed track for the
heatmaps and profiles. Sequencing datasets are listed in Table EV3.
Gene expression analyses
Total RNA was purified using RNeasy Mini Kit (Qiagen) including
on-column DNase treatment. First-strand cDNA was synthesised
using SuperScript IV reverse transcriptase (Invitrogen) and random
hexamers. Quantitative PCRs (qPCRs) were performed using
TaqMan reagents (Applied Biosystems) on a QuantStudio Flex Real-
Time PCR System (Applied Biosystems) or a StepOne Real-Time
PCR System (Applied Biosystems). Gene expression was determined
relative to housekeeping genes using the DCt method. TaqMan
assays or PCR primers are listed in Table 1.
RNA-seq
Libraries for sequencing were prepared using the NEXTflex Rapid
Directional RNA-seq kit (Illumina) or SMARTer Stranded Total
RNA-Seq Kit v2—Pico Input Mammalian (Takara Bio) and
sequenced on the Illumina platform as for ChIP-seq libraries. Low-
quality reads and adaptor sequences were removed by Trim Galore!
(version: 0.4.1), and the trimmed reads were aligned to mouse refer-
ence genome (GRCm38/mm10) using Tophat (version v2.1.0; Kim
et al, 2013). Read counts per gene were obtained using feature-
Counts (version 1.5.0; Liao et al, 2014) with annotations from
Ensembl release 86 (Yates et al, 2016). Normalisation, with and
without spike-ins, and differential expression analyses were
performed using the R/Bioconductor Deseq2 package (version
1.14.1; Love et al, 2014). The R prcomp function was used for prin-
cipal component analysis (PCA). Gene Ontology (GO) analysis was
performed using DAVID (da Huang et al, 2009b).
Statistical analyses
No power calculations were performed to predetermine sample
sizes. Statistical analyses were performed using GraphPad Prism
Table 1. List of TaqMan assays and primers used for gene expression
analyses.
Gene TaqMan assay
Ascl1 Mm03058063_m1
Atp5a1 Mm00431960_m1
Bmp4 Mm00432087_m1
Cdh2 Mm01162497_m1
Cdx2 Mm01212280_m1
Esrrb Mm00442411_m1
Eomes Mm01351985_m1
Elf5 Mm00468732_m1
Foxa2 Mm01976556_s1
Gapdh Mm99999915_g1
Gata3 Mm00484683_m1
Gata6 Mm00802636_m1
Klf4 Mm00516104_m1
Nanog Mm02019550_s1
Nestin Mm00450205_m1
Nodal Mm00443040_m1
Pax6 Mm00443081_m1
Pou5f1 Mm03053917_g1
Ppia Mm02342430_g1
Sox1 Mm00486299_s1
Sox17 Mm00488363_m1
T Mm00436877_m1
Tbp Mm00446971_m1
Zfp42 Mm03053975_g1
Gene Forward primer (50–30) Reverse primer (50–30)
Ebf4 AACTGCGGGTCCTTATGTTC TTTGTCTTTTCCGTCCCAGG
Hcn4 CCCGCCTCATTCGATACATT AGCAGAAGCATCATGCCAAT
Nobox CCTACGGAGAAGCTCTGCAA TCTGGGGGAGAACAACCTTC
Sfrp2 AATGAGGACGACAACGACAT ACGCCGTTCAGCTTGTAAAT
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software. Images of cells or embryos are representative of at least
three independent experiments. Statistical methods used to analyse
high throughput sequencing data and proteomics data are described
in the respective sections of the Materials and Methods.
Data availability
High throughput sequence datasets used in this manuscript are
listed in Table EV3. ChIP-seq data are available with the GEO acces-
sion number GSE122833 (https://www.ncbi.nlm.nih.gov/geo/que
ry/acc.cgi?acc=GSE122833). RNA-seq data are available with the
GEO accession number GSE122696 (https://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE122696). The mass spectrometry
proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE partner repository with the dataset identi-
fier PXD009855 (https://www.ebi.ac.uk/pride/archive/projects/
PXD009855). All original western blot images are available at
Mendeley Data: https://doi.org/10.17632/d25bgfn8hd.1.
Expanded View for this article is available online.
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